We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$289B
AUM Growth
+$17B
Cap. Flow
+$19B
Cap. Flow %
6.57%
Top 10 Hldgs %
11.8%
Holding
7,065
New
213
Increased
3,439
Reduced
2,832
Closed
120
Avg Time Held
6.7 quarters
Top 10 Avg Time Held
5 quarters
Top 20 Avg Time Held
5.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.23%
2 Healthcare 10.87%
3 Financials 9.03%
4 Technology 8.57%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HMNF icon
6576
DELISTED
HMN Financial Inc
HMNF
$0 ﹤0.01%
9
+1
+13% +$12
2014 Q1
5 quarters
BIMI icon
6577
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
– –
0
– –
2014 Q1
5 quarters
DYNT icon
6578
DELISTED
Dynatronics Corp
DYNT
$0 ﹤0.01%
1
– –
2014 Q1
5 quarters
TCON
6579
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-11
Closed -$31K –
ALPN icon
6580
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
0
– –
2015 Q2
0 quarters
AVGR icon
6581
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$9K
2015 Q1
1 quarter
CTHR icon
6582
DELISTED
Charles & Colvard Ltd
CTHR
$0 ﹤0.01%
63
– –
2013 Q3
7 quarters
NURO icon
6583
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
– –
0
– –
2014 Q3
3 quarters
MARK
6584
DELISTED
Remark Holdings, Inc.
MARK
$0 ﹤0.01%
2
– –
2014 Q1
5 quarters
BETS
6585
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
– –
0
– –
2015 Q2
0 quarters
AEY
6586
DELISTED
ADDvantage Technologies Group
AEY
$0 ﹤0.01%
2
-26
-93% -$616
2014 Q1
5 quarters
YVR
6587
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
– –
0
– –
2014 Q1
5 quarters
OFED
6588
DELISTED
Oconee Federal Financial Corp.
OFED
$0 ﹤0.01%
9
-1
-10% -$20
2014 Q1
5 quarters
TCFC
6589
DELISTED
The Community Financial Corporation Common Stock
TCFC
$0 ﹤0.01%
8
-4,500
-100% -$93.3K
2014 Q1
5 quarters
BNSO
6590
DELISTED
Bonso Electronic International
BNSO
$0 ﹤0.01%
10
+1
+11% +$2
2014 Q1
5 quarters
UNAM
6591
DELISTED
Unico American Corp
UNAM
$0 ﹤0.01%
10
+1
+11% +$11
2014 Q1
5 quarters
LMST
6592
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$0 ﹤0.01%
7
+2
+40% +$12
2014 Q1
5 quarters
APEN
6593
DELISTED
Apollo Endosurgery, Inc.
APEN
$0 ﹤0.01%
6
+1
+20% +$99
2013 Q4
6 quarters
ALBO
6594
DELISTED
Albireo Pharma Inc
ALBO
$0 ﹤0.01%
10
+9
+900% +$302
2013 Q4
6 quarters
AHPI
6595
DELISTED
Allied Healthcare Products
AHPI
$0 ﹤0.01%
7
– –
2014 Q1
5 quarters
SMIT
6596
DELISTED
Schmitt Industries Inc
SMIT
$0 ﹤0.01%
5
– –
2014 Q1
5 quarters
EMCF
6597
DELISTED
Emclaire Financial Corp
EMCF
$0 ﹤0.01%
4
+1
+33% +$24
2014 Q1
5 quarters
RJA
6598
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$0 ﹤0.01%
66
– –
2013 Q2
8 quarters
OBCI
6599
DELISTED
Ocean Bio-Chem Inc
OBCI
$0 ﹤0.01%
+16
New +$61
2015 Q2
0 quarters
XELA icon
6600
DELISTED
Exela Technologies, Inc. Common Stock
XELA
– –
0
– –
2015 Q2
0 quarters

Similar funds

Morgan Stanley's Q2 2015 Portfolio in Review

As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.

  • Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
  • Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
  • Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
  • Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
  • Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
  • Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
  • Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.